The SUB-urothelial DUrvalumab InjEction (SUBDUE-1) trial: first-in-human trial in patients with bladder cancer

Dickon Hayne

Surgery

Press/Media: Press / Media

Description

A media article describing SUBDUE-1 - a first-in-human trial that assessed the safety and feasibility of injection of durvalumab into the bladder for patients planned for radical cystectomy.

Period	19 Mar 2024

Media contributions

Title	The SUB-urothelial DUrvalumab InjEction (SUBDUE-1) trial: first-in-human trial in patients with bladder cancer
Media name/outlet	URO Today
Country/Territory	Australia
Date	19/03/24
Description	Media article describing the SUBDUE-1 trial
URL	https://www.urotoday.com/recent-abstracts/urologic-oncology/bladder-cancer/150415-the-sub-urothelial-durvalumab-injection-1-subdue-1-trial-first-in-human-trial-in-patients-with-bladder-cancer.html
Persons	Dickon Hayne

View all 1

View less